Click here - to use the wp menu builder
Search
Maverick Times
News with a
DIFFERENCE
Maverick Times
News with a
Difference
Go
Search
No menu items!
Category:
International news
Agency Copies
Banking News
Business news
Coronavirus
Crime news
Defence news
Entertainment news
This 14-year-old kid raised 665K to purchase oxygen concentrators in the fight against Covid19
Agency Copies
U.S. Food & Drug Administration Grants Priority Review of Maribavir for the Treatment of Post-Transplant Recipients With Cytomegalovirus Infection in Those Resistant and/or Refractory...
Agency Copies
Data from Merck’s Oncology Portfolio Highlight Significant Advances in Cancer Care at ASCO21
International news
Call to boycott Chinese goods gets louder; 71% of Indians boycotted Chinese goods this Diwali
International news
‘I won’t be the last’: Kamala Harris promises little girls
Crime news
NXIVM Vanguard Keith Raniere Has Been Sentenced to 120 Years in Prison
International news
Akal Takht denounces Same-sex marriage in presence of Guru Granth Sahib: US
International news
Pakistan removes names of more than 5,000 people from travel blacklist
International news
India seeks release of four prisoners, approaches Pakistan Court
International news
Pakistan Re-elected to UN Human Rights Council; China Sees Drastic Drop Standing
Environment news
CBI investigates, seized Sea cucumbers worth Rs 20lakh: Lakshadweep
Business news
Elon Musk indicates entry of Tesla in India
Load more
This 14-year-old kid raised 665K to purchase oxygen concentrators in the fight against Covid19
May 23, 2021
U.S. Food & Drug Administration Grants Priority Review of Maribavir for the Treatment of Post-Transplant Recipients With Cytomegalovirus Infection in Those Resistant and/or Refractory...
May 22, 2021
Data from Merck’s Oncology Portfolio Highlight Significant Advances in Cancer Care at ASCO21
May 22, 2021
CHMP issues positive opinion for Jardiance® (empagliflozin) for the treatment of adults with heart failure with reduced ejection fraction
May 22, 2021
Ferring and Rebiotix Present Landmark Phase 3 Data Demonstrating Superior Efficacy of Investigational RBX2660 Versus Placebo to Reduce Recurrence of C. difficile Infection
May 22, 2021